vs
Side-by-side financial comparison of STEM, INC. (STEM) and ThredUp Inc. (TDUP). Click either name above to swap in a different company.
ThredUp Inc. is the larger business by last-quarter revenue ($79.7M vs $47.1M, roughly 1.7× STEM, INC.). ThredUp Inc. runs the higher net margin — -7.0% vs -33.9%, a 26.9% gap on every dollar of revenue. On growth, ThredUp Inc. posted the faster year-over-year revenue change (18.5% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 11.1%).
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
ThredUp Inc. is an American company that operates an online resale platform specializing in the sale of second-hand clothing, footwear, and accessories. Founded in 2009 and headquartered in Oakland, California, it has established itself as one of the leading resale fashion marketplaces.
STEM vs TDUP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.1M | $79.7M |
| Net Profit | $-16.0M | $-5.6M |
| Gross Margin | 48.9% | 79.6% |
| Operating Margin | -17.7% | -8.4% |
| Net Margin | -33.9% | -7.0% |
| Revenue YoY | -15.6% | 18.5% |
| Net Profit YoY | 68.8% | 74.3% |
| EPS (diluted) | $-4.40 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.1M | $79.7M | ||
| Q3 25 | $38.2M | $82.2M | ||
| Q2 25 | $38.4M | $77.7M | ||
| Q1 25 | $32.5M | $71.3M | ||
| Q4 24 | $55.8M | $67.3M | ||
| Q3 24 | $29.3M | $61.5M | ||
| Q2 24 | $34.0M | $66.7M | ||
| Q1 24 | $25.5M | $64.5M |
| Q4 25 | $-16.0M | $-5.6M | ||
| Q3 25 | $-23.8M | $-4.2M | ||
| Q2 25 | $202.5M | $-5.2M | ||
| Q1 25 | $-25.0M | $-5.2M | ||
| Q4 24 | $-51.1M | $-21.7M | ||
| Q3 24 | $-148.3M | $-24.8M | ||
| Q2 24 | $-582.3M | $-14.0M | ||
| Q1 24 | $-72.3M | $-16.6M |
| Q4 25 | 48.9% | 79.6% | ||
| Q3 25 | 35.5% | 79.4% | ||
| Q2 25 | 33.4% | 79.5% | ||
| Q1 25 | 32.4% | 79.1% | ||
| Q4 24 | -4.4% | 80.4% | ||
| Q3 24 | 21.2% | 79.3% | ||
| Q2 24 | 27.6% | 78.8% | ||
| Q1 24 | -95.0% | 80.1% |
| Q4 25 | -17.7% | -8.4% | ||
| Q3 25 | -33.6% | -5.3% | ||
| Q2 25 | -34.8% | -6.8% | ||
| Q1 25 | -65.0% | -7.6% | ||
| Q4 24 | -84.4% | -12.1% | ||
| Q3 24 | -493.2% | -17.0% | ||
| Q2 24 | -1705.5% | -14.4% | ||
| Q1 24 | -267.0% | -19.2% |
| Q4 25 | -33.9% | -7.0% | ||
| Q3 25 | -62.2% | -5.2% | ||
| Q2 25 | 527.8% | -6.7% | ||
| Q1 25 | -76.9% | -7.3% | ||
| Q4 24 | -91.6% | -32.3% | ||
| Q3 24 | -506.3% | -40.3% | ||
| Q2 24 | -1712.6% | -20.9% | ||
| Q1 24 | -283.9% | -25.7% |
| Q4 25 | $-4.40 | $-0.06 | ||
| Q3 25 | $-2.84 | $-0.03 | ||
| Q2 25 | $-1.79 | $-0.04 | ||
| Q1 25 | $-0.15 | $-0.04 | ||
| Q4 24 | $-15.29 | $-0.19 | ||
| Q3 24 | $-18.24 | $-0.22 | ||
| Q2 24 | $-71.81 | $-0.13 | ||
| Q1 24 | $-0.46 | $-0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $48.9M | $38.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-249.4M | $59.2M |
| Total Assets | $308.9M | $167.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $48.9M | $38.6M | ||
| Q3 25 | $43.1M | $46.2M | ||
| Q2 25 | $40.8M | $41.0M | ||
| Q1 25 | $58.6M | $41.1M | ||
| Q4 24 | $56.3M | $31.9M | ||
| Q3 24 | $75.4M | $43.7M | ||
| Q2 24 | $89.6M | $44.8M | ||
| Q1 24 | $112.8M | $50.1M |
| Q4 25 | $-249.4M | $59.2M | ||
| Q3 25 | $-235.7M | $59.1M | ||
| Q2 25 | $-214.1M | $60.2M | ||
| Q1 25 | $-417.5M | $56.1M | ||
| Q4 24 | $-398.4M | $56.3M | ||
| Q3 24 | $-344.1M | $69.3M | ||
| Q2 24 | $-203.2M | $86.5M | ||
| Q1 24 | $371.6M | $93.5M |
| Q4 25 | $308.9M | $167.2M | ||
| Q3 25 | $362.6M | $172.5M | ||
| Q2 25 | $379.2M | $173.6M | ||
| Q1 25 | $405.1M | $172.5M | ||
| Q4 24 | $437.4M | $171.2M | ||
| Q3 24 | $537.8M | $214.9M | ||
| Q2 24 | $691.5M | $231.2M | ||
| Q1 24 | $1.3B | $244.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $-1.5M |
| Free Cash FlowOCF − Capex | — | $-3.2M |
| FCF MarginFCF / Revenue | — | -4.0% |
| Capex IntensityCapex / Revenue | — | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $180.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $-1.5M | ||
| Q3 25 | $11.4M | $6.0M | ||
| Q2 25 | $-21.3M | $344.0K | ||
| Q1 25 | $8.5M | $5.7M | ||
| Q4 24 | $-14.7M | $663.0K | ||
| Q3 24 | $-9.4M | $3.3M | ||
| Q2 24 | $-11.9M | $-5.0M | ||
| Q1 24 | $-621.0K | $1.4M |
| Q4 25 | — | $-3.2M | ||
| Q3 25 | — | $2.4M | ||
| Q2 25 | — | $-2.9M | ||
| Q1 25 | — | $3.9M | ||
| Q4 24 | — | $-1.8M | ||
| Q3 24 | — | $1.2M | ||
| Q2 24 | — | $-5.8M | ||
| Q1 24 | — | $267.0K |
| Q4 25 | — | -4.0% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | -3.8% | ||
| Q1 25 | — | 5.5% | ||
| Q4 24 | — | -2.7% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | -8.7% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | — | 3.5% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.11× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
